Acute Pancreatitis Pathogenesis

Acute pancreatitis is generally considered to occur in three phases.

First phase

This phase involves a premature activation of the powerful enzyme called trypsin. Normally the pancreas contains trypsin in an inactive form within the acinar cells. Once it is released in the gut this enzyme breaks down proteins present in the food.

The pancreatic cells are protected from this enzyme by its presence as an inactive form within the pancreas. In the first phase of pancreatitis there is premature activation of this enzyme called trypsin.

There are several mechanisms by which this premature activation may take place. There may be a disruption of calcium signaling in acinar cells or breakdown of trypsinogen to trypsin by the enzyme lysosomal hydrolase cathepsin-B or decreased activity of the intracellular pancreatic trypsin inhibitor.

Once activated trypsin in turn activates several pancreatic digestive enzymes. These enzymes bring in the process of self digestion of the pancreatic cells.

Second phase

In this phase the activated trypsin causes inflammation within the pancreas.

Third phase

In this phase the inflammation within the pancreas spreads to other organs for example acute respiratory syndrome (ARDS).

Both the second and third phase of inflammation is medicated by cytokines and other inflammatory mediators. These mediators lead to activation of inflammatory cells and this set in a chain of events. The other inflammatory cells are activated and these bind to the cells lining the blood vessels.

There is activation blood coagulation or clotting factors. These spread to other organs as well via blood. The blood vessel walls become leaky and begin to release the inflammatory cells. In addition to inflammatory cells, free radicals are also released along with other chemical mediators of inflammation like cytokines (tumor necrosis factor (TNF), interleukins, arachidonic acid metabolites, platelet activator factor, leukotrines, prostaglandins, substance P, mitogen-activated protein kinase, P-selectin or E-selectin, heat shock proteins etc.

In most patients acute pancreatitis is mild. In around 10 to 20% patients there may be severe inflammation. This may lead to systemic inflammatory response syndrome (SIRS). Gall bladder stone and alcohol consumption are linked to acute pancreatitis.

Further Reading

Last Updated: Jul 2, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 02). Acute Pancreatitis Pathogenesis. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/health/Acute-Pancreatitis-Pathogenesis.aspx.

  • MLA

    Mandal, Ananya. "Acute Pancreatitis Pathogenesis". News-Medical. 21 November 2024. <https://www.news-medical.net/health/Acute-Pancreatitis-Pathogenesis.aspx>.

  • Chicago

    Mandal, Ananya. "Acute Pancreatitis Pathogenesis". News-Medical. https://www.news-medical.net/health/Acute-Pancreatitis-Pathogenesis.aspx. (accessed November 21, 2024).

  • Harvard

    Mandal, Ananya. 2023. Acute Pancreatitis Pathogenesis. News-Medical, viewed 21 November 2024, https://www.news-medical.net/health/Acute-Pancreatitis-Pathogenesis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.